title: Fecal Microbiota Transplantation for Clostridium difficile-Associated Diarrhea.
abstract: Clostridium difficile-associated diarrhea is a problem most hospital-based physicians will face in their career. This review aims to refresh current knowledge with regard to Clostridium difficile infection and bring physicians up to date with the latest developments in the growing field of fecal microbiota transplantation, the benefits it offers, and the promise this and other developments hold for the future.
authors.forename: Nathaniel A
authors.initials: NA
authors.lastname: Cohen
authors.forename: Ronen
authors.initials: R
authors.lastname: Ben Ami
authors.forename: Hanan
authors.initials: H
authors.lastname: Guzner-Gur
authors.forename: Moshe E
authors.initials: ME
authors.lastname: Santo
authors.forename: Zamir
authors.initials: Z
authors.lastname: Halpern
authors.forename: Nitsan
authors.initials: N
authors.lastname: Maharshak
mesh_terms: D000900:Anti-Bacterial Agents / Q000009:adverse effects; D016360:Clostridioides difficile / Q000302:isolation & purification; D004761:Enterocolitis, Pseudomembranous / Q000209:etiology / Q000382:microbiology / Q000628:therapy; D005243:Feces / Q000382:microbiology*; D041981:Gastrointestinal Tract / Q000382:microbiology / Q000503:physiopathology; D006801:Humans; D064307:Microbiota / Q000187:drug effects / Q000502:physiology; D017063:Outcome Assessment, Health Care; D019737:Transplants / Q000382:microbiology*
chemical_list: D000900:Anti-Bacterial Agents